ARISE-A randomized, double-blind, placebo-controlled, active comparator, multicenter study to validate patient-reported outcome instruments in adult subjects with newly diagnosed nontuberculous mycobacterial (NTM) lung infection caused by MAC.

Administered By

Awarded By

Contributors

Start/End

  • May 12, 2021 - May 14, 2026